Description

Book Synopsis

The inaugural volume in the Current Topics in Nonclinical Drug Development Series explores the critical issues and current topics in nonclinical drug development. This first volume covers individual topics and strategies in drug development from compound characterization to drug registration. Written by a variety of experts in the field, recent and rapid advances in technologies and associated changes in regulatory guidance are discussed.

Additional features include:

  • Deals with day-to-day issues in study design, evaluation of findings, and presentation of data.
  • Explains new approaches in the development of medical devices.
  • Includes dedicated chapters on the use of bioinformatics in drug development.
  • Addresses strategies for photosafety testing of drugs.

Current Topics in Nonclinical Drug Development, Volume I will aid toxicologists, toxicologic pathologists, consultants, regul

Table of Contents

Contents

PREFACE VII

ACKNOWLEDGMENTS IX

EDITORS XI

CONTRIBUTORS XV

1 Bioinformatics/Impact of Computational Biology

for Molecular Safety Assessment during Drug

Development 1

JULIANE PERNER, MEGUMI ONISHI-SEEBACHER,

ALBERTO DEL RIO ESPINOLA, ELAINE TRITTO, PHILIPPE COUTTET,

RÉMI TERRANOVA, AND JONATHAN MOGGS

2 Integrating Toxicogenomics Data into Risk

Assessment 23

ARUN R. PANDIRI, WARREN CASEY, AND SCOTT S. AUERBACH

3 New Approaches in Development

of Medical Devices 53

SHANNON M. WALLACE, PEGGY A. LALOR,

AND KATHLEEN A. FUNK

4 Recent Advances in the Development

of Novel Biomarkers of Toxicity 81

DOMINIQUE BREES, DANA WALKER, DAVID LEDIEU,

DAVID BROTT MICHAEL MERZ, AND JACQUELINE TARRANT

5 Preclinical Evaluation and Translational

Development of Cell and Gene Therapies 121

SHON GREEN, TIMOTHY K. MACLACHLAN, JENNIFER L.

MARLOWE, AND PRASHANT NAMBIAR

6 Value of Juvenile Toxicity Studies 185

PAUL BALDRICK

7 Photosafety Testing of Drugs 223

ANTHONY M. LYNCH AND DANIEL BAUER

8 Combination Safety Assessment During Drug

Development 275

JOANNE BIRKEBAK, SHERRY L. RALSTON,

AND LEIGH ANN BURNS-NAAS

INDEX 307

Current Topics in Nonclinical Drug Development

    Product form

    £999.99

    Includes FREE delivery

    A Hardback by Pritam S. Sahota, Philip Bentley, Zbigniew Wojcinski

    Out of stock


      View other formats and editions of Current Topics in Nonclinical Drug Development by Pritam S. Sahota

      Publisher: CRC Press
      Publication Date: 12/23/2020 12:00:00 AM
      ISBN13: 9780367136277, 978-0367136277
      ISBN10: 0367136279

      Description

      Book Synopsis

      The inaugural volume in the Current Topics in Nonclinical Drug Development Series explores the critical issues and current topics in nonclinical drug development. This first volume covers individual topics and strategies in drug development from compound characterization to drug registration. Written by a variety of experts in the field, recent and rapid advances in technologies and associated changes in regulatory guidance are discussed.

      Additional features include:

      • Deals with day-to-day issues in study design, evaluation of findings, and presentation of data.
      • Explains new approaches in the development of medical devices.
      • Includes dedicated chapters on the use of bioinformatics in drug development.
      • Addresses strategies for photosafety testing of drugs.

      Current Topics in Nonclinical Drug Development, Volume I will aid toxicologists, toxicologic pathologists, consultants, regul

      Table of Contents

      Contents

      PREFACE VII

      ACKNOWLEDGMENTS IX

      EDITORS XI

      CONTRIBUTORS XV

      1 Bioinformatics/Impact of Computational Biology

      for Molecular Safety Assessment during Drug

      Development 1

      JULIANE PERNER, MEGUMI ONISHI-SEEBACHER,

      ALBERTO DEL RIO ESPINOLA, ELAINE TRITTO, PHILIPPE COUTTET,

      RÉMI TERRANOVA, AND JONATHAN MOGGS

      2 Integrating Toxicogenomics Data into Risk

      Assessment 23

      ARUN R. PANDIRI, WARREN CASEY, AND SCOTT S. AUERBACH

      3 New Approaches in Development

      of Medical Devices 53

      SHANNON M. WALLACE, PEGGY A. LALOR,

      AND KATHLEEN A. FUNK

      4 Recent Advances in the Development

      of Novel Biomarkers of Toxicity 81

      DOMINIQUE BREES, DANA WALKER, DAVID LEDIEU,

      DAVID BROTT MICHAEL MERZ, AND JACQUELINE TARRANT

      5 Preclinical Evaluation and Translational

      Development of Cell and Gene Therapies 121

      SHON GREEN, TIMOTHY K. MACLACHLAN, JENNIFER L.

      MARLOWE, AND PRASHANT NAMBIAR

      6 Value of Juvenile Toxicity Studies 185

      PAUL BALDRICK

      7 Photosafety Testing of Drugs 223

      ANTHONY M. LYNCH AND DANIEL BAUER

      8 Combination Safety Assessment During Drug

      Development 275

      JOANNE BIRKEBAK, SHERRY L. RALSTON,

      AND LEIGH ANN BURNS-NAAS

      INDEX 307

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account